PyInvesting

Market research

FAGR.BR Fagron NV

BR EUR Healthcare

Latest close

24.40 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
2B
P/E ratio
19.36
Analyst target
29
Dividend yield
1.7%
Beta
0.32

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Fagron NV is currently in a long term downtrend where the price is trading 8.6% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.

Fagron NV's total revenue sank by 0.0% to $140M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $14M since the same quarter in the previous year.

Finally, its free cash flow grew by 105.2% to $29M since the same quarter in the previous year.

Based on the above factors, Fagron NV gets an overall score of 2/5.